KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Intangibles (2018 - 2025)

Historic Intangibles for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $2.2 million.

  • Adaptive Biotechnologies' Intangibles fell 4406.96% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 4406.96%. This contributed to the annual value of $3.4 million for FY2024, which is 8314.88% down from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Intangibles is $2.2 million, which was down 4406.96% from $2.6 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Intangibles high stood at $20.3 million for Q1 2021, and its period low was $2.2 million during Q3 2025.
  • Its 5-year average for Intangibles is $11.8 million, with a median of $6.4 million in 2023.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Intangibles changed by 0.0% in 2021, and later plummeted by 8314.88% in 2024.
  • Adaptive Biotechnologies' Intangibles (Quarter) stood at $20.3 million in 2021, then changed by 0.0% to $20.3 million in 2022, then changed by 0.0% to $20.3 million in 2023, then crashed by 83.15% to $3.4 million in 2024, then plummeted by 37.08% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.6 million for Q2 2025, and $3.0 million during Q1 2025.